Screener
Immunovant, Inc. IMVT Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026.
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
| Line item | March 31, 2026 | March 31, 2025 |
|---|---|---|
| Total current assets | 948,819 | 767,662 |
| Operating lease right-of-use assets | 72 | 98 |
| Property and equipment, net | 443 | 844 |
| Other assets | 7,680 | 7,618 |
| Total assets | $957,014 | $776,222 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $7,541 | $17,656 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Immunovant, Inc.'s other non-current assets?
- Immunovant, Inc. (IMVT) reported other non-current assets of $7.68M in Q1 2026.
- How has Immunovant, Inc.'s other non-current assets changed year-over-year?
- Immunovant, Inc.'s other non-current assets increased by 0.8% year-over-year, from $7.62M to $7.68M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Immunovant, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude